| Mountain View Eye Care Center P C | |
|
14415 Se Mill Plain Blvd, Ste. 115-b, Vancouver, WA 98684-3543 | |
| (360) 253-4405 | |
| Not Available |
| Full Name | Mountain View Eye Care Center P C |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 14415 Se Mill Plain Blvd, Vancouver, Washington |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093035305 | NPI | - | NPPES |
| 2008217 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Christen Jankowski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255393849 PECOS PAC ID: 7911038906 Enrollment ID: I20100709000167 |
News Archive
NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.
Many Christian and political conservatives in the U.S. support legislation to deny sexual and gender minorities the rights most Americans enjoy: unfettered access to jobs, housing, services and public facilities; the opportunity to marry as they choose; and the right to adopt a child.
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.
Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.
› Verified 1 days ago
| Provider Name | Shannon Soper |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215323464 PECOS PAC ID: 1254624687 Enrollment ID: I20160722001763 |
News Archive
NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.
Many Christian and political conservatives in the U.S. support legislation to deny sexual and gender minorities the rights most Americans enjoy: unfettered access to jobs, housing, services and public facilities; the opportunity to marry as they choose; and the right to adopt a child.
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.
Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.
› Verified 1 days ago
| Provider Name | Nicholas Jeffrey Jankowski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1659766004 PECOS PAC ID: 4880974906 Enrollment ID: I20161207001958 |
News Archive
NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.
Many Christian and political conservatives in the U.S. support legislation to deny sexual and gender minorities the rights most Americans enjoy: unfettered access to jobs, housing, services and public facilities; the opportunity to marry as they choose; and the right to adopt a child.
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.
Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.
› Verified 1 days ago
| Provider Name | Olga Kraushaar |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1326758764 PECOS PAC ID: 3274996939 Enrollment ID: I20230828003299 |
News Archive
NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.
Many Christian and political conservatives in the U.S. support legislation to deny sexual and gender minorities the rights most Americans enjoy: unfettered access to jobs, housing, services and public facilities; the opportunity to marry as they choose; and the right to adopt a child.
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.
Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mountain View Eye Care Center P C 14415 Se Mill Plain Blvd, Ste. 115-b, Vancouver, WA 98684-3543 Ph: (360) 253-4405 | Mountain View Eye Care Center P C 14415 Se Mill Plain Blvd, Ste. 115-b, Vancouver, WA 98684-3543 Ph: (360) 253-4405 |
News Archive
NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.
Many Christian and political conservatives in the U.S. support legislation to deny sexual and gender minorities the rights most Americans enjoy: unfettered access to jobs, housing, services and public facilities; the opportunity to marry as they choose; and the right to adopt a child.
Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.
Around 2.5 million people are affected by the autoimmune disease Multiple Sclerosis (MS), the commonest central nervous system disease among young adults.
› Verified 1 days ago
Dr. Marvin Arnold Helde, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12607 Se Mill Plain Blvd, Kaiser Permanente Cascade Park Medical Facility, Vancouver, WA 98684 Phone: 360-896-4456 | |
Advanced Eye Care Center, P.s. Optometrist Medicare: Medicare Enrolled Practice Location: 2100 Se 164th Ave, Suite D104, Vancouver, WA 98683 Phone: 360-256-0203 | |
John E Thompson, Optometrist Medicare: Medicare Enrolled Practice Location: 14901 Nw 25th Ave, Vancouver, WA 98685 Phone: 360-573-7564 | |
Clearly Lasik Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1325 Se Tech Center Dr, Suite 110, Vancouver, WA 98683 Phone: 360-635-5000 Fax: 360-635-5001 | |
Andrea Morton, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 314 E Mcloughlin Blvd, Vancouver, WA 98663 Phone: 360-694-8303 Fax: 360-694-9032 | |
Dr. Alexander S Choy, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2525 Ne 139th St Ste 280, Vancouver, WA 98686 Phone: 360-882-2778 Fax: 360-604-1780 | |
Mrs. Linda R Medeski-nicacio, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 912 Main St, Vancouver, WA 98660 Phone: 360-694-6541 Fax: 360-696-2578 |